Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas

doi:10.3748/wjg.v17.i14.1866

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4194)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

371

HTML

3341

Figures (1-3)

241

Tables (1-3)

242

Sum=4195

Apr 14, 2011 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 14, 2011; 17(14): 1866-1873
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1866

Table 1 Glucose transporter 1 expression in normal mucosa, tubular adenomas, adenocarcinomas, and metastatic lesions (n = 718)

Tissue samples	n	Expression of GLUT1				P value
Tissue samples	n	Negative (%)	Low (%)	Moderate (%)	High (%)	(χ²-test)
Normal mucosa	26	26 (100.0)	0 (0.0)	0 (0.0)	0 (0.0)	< 0.001¹
Tubular adenomas with LGD	26	21 (80.8)	5 (19.2)	0 (0.0)	0 (0.0)
Tubular adenomas with HGD	24	10 (41.7)	9 (37.5)	5 (20.8)	0 (0.0)
Adenocarcinomas	515	92 (17.9)	75 (14.6)	161 (31.2)	187 (36.3)
Metastatic lesions	127	31 (24.4)	15 (11.8)	22 (17.3)	59 (46.5)

¹: χ² test for linear trend. LGD: Low grade dysplasia; HGD: High grade dysplasia; GLUT1: Glucose transporter 1; Metastatic lesions; lymph nodes and distant organs.

Citation: Jun YJ, Jang SM, Han HL, Lee KH, Jang KS, Paik SS. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol 2011; 17(14): 1866-1873
URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1866.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1866